INM (InMed Pharmaceuticals Inc. Common Shares) Stock Analysis - SEC Filings

InMed Pharmaceuticals Inc. Common Shares (INM) is a publicly traded Healthcare sector company. As of May 19, 2026, INM trades at $1.42 with a market cap of $2.12M and a P/E ratio of -0.08. INM moved +125.50% today. Year to date, INM is -39.22%; over the trailing twelve months it is -76.93%. Its 52-week range spans $0.58 to $8.27. Rallies surfaces INM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find INM SEC filings?

Rallies organizes INM SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

INM Key Metrics

Key financial metrics for INM
MetricValue
Price$1.42
Market Cap$2.12M
P/E Ratio-0.08
EPS$-8.36
Dividend Yield0.00%
52-Week High$8.27
52-Week Low$0.58
Volume70.34M
Avg Volume0
Revenue (TTM)$4.94M
Net Income$-8.16M
Gross Margin34.53%

Latest INM News

Recent INM Insider Trades

  • MANCINI ALEXANDRA DIANE JANET sold 240 (~$42.312) on Jul 31, 2024.
  • HULL ANDREW bought 37.50K (~$14.63K) on Feb 21, 2024.
  • ADAMS ERIC A bought 41.60K (~$14.92K) on Feb 20, 2024.

INM Analyst Consensus

INM analyst coverage data. Average price target: $0.00.

Common questions about INM

Where can I find INM SEC filings?
Rallies organizes INM SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show INM 10-K and 10-Q filings?
Rallies organizes INM SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is INM research on Rallies investment advice?
No. Rallies provides research, data, and educational context for INM. It does not provide personalized investment advice.
INM

INM